1. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
- Author
-
Amit S. Yadav, Poonam R. Pandey, Ramesh Butti, N. N. V. Radharani, Shamayita Roy, Shaileshkumar R. Bhalara, Mahadeo Gorain, Gopal C. Kundu, and Dhiraj Kumar
- Subjects
0301 basic medicine ,reactivation ,Cancer Research ,dormancy ,medicine.medical_treatment ,Cancer metastasis ,Review ,Biology ,lcsh:RC254-282 ,03 medical and health sciences ,cancer metastasis ,Adjuvant therapy ,medicine ,tumor microenvironment ,Epithelial–mesenchymal transition ,Cause of death ,Tumor microenvironment ,epithelial to mesenchymal transition ,Cancer ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Radiation therapy ,030104 developmental biology ,Oncology ,Cancer research ,Dormancy - Abstract
Advancements in the early detection of cancer coupled with improved surgery, radiotherapy, and adjuvant therapy led to substantial increase in patient survival. Nevertheless, cancer metastasis is the leading cause of death in several cancer patients. The majority of these deaths are associated with metastatic relapse kinetics after a variable period of clinical remission. Most of the cancer recurrences are thought to be associated with the reactivation of dormant disseminated tumor cells (DTCs). In this review, we have summarized the cellular and molecular mechanisms related to DTCs and the role of microenvironmental niche. These mechanisms regulate the dormant state and help in the reactivation, which leads to metastatic outgrowth. Identification of novel therapeutic targets to eliminate these dormant tumor cells will be highly useful in controlling the metastatic relapse-related death with several cancers.
- Published
- 2018
- Full Text
- View/download PDF